The Platform Group's Shares Hit New Low as Legal Disputes and Loan Tensions Eclipse Strong Q1 Results

Despite a 51% revenue jump and €1B target, The Platform Group's shares hit a 52-week low amid legal battles, loan terminations, and a pending acquisition deadline.

A 51% jump in first-quarter revenues and a reiterated €1 billion annual sales target might normally steady a stock. For The Platform Group, however, operating strength has been utterly overshadowed by a cascade of legal headaches and financing doubts that drove the share price to a 52-week low of exactly €1.20 — an 8.75% plunge on the day. Two days later, the shares had recovered only marginally to €1.30, still flirting with the abyss.

The Düsseldorf-based company is fighting on multiple fronts. A recent report from manager magazin raised uncomfortable questions about bank loans, prompting the group to denounce what it calls a targeted campaign. Law firm LHR is preparing a damages claim, while the Chemnitz public prosecutor’s office is examining a criminal complaint over alleged forgery and fraud — accusations management flatly denies. The BaFin, Germany’s financial regulator, has reportedly received a corresponding tip-off concerning disputed signatures on joint liability declarations by subsidiary managers.

The credit side is equally troubling. Landesbank Baden-Württemberg (LBBW) has terminated a loan and is demanding repayment of roughly €6.75 million, which The Platform Group insists has already been fully settled. Meanwhile, Sparkasse Essen is reportedly seeking a further €5.1 million, though the company points to a binding repayment agreement. The resulting uncertainty has spooked the market, with the relative strength index (RSI) touching 21 (in the primary article) and later edging up to 22.2 — deep into oversold territory. With annualised volatility at 128%, however, that technical signal offers little comfort.

In an attempt to shore up confidence, the board resolved on 17 June to launch a bond buyback program for the outstanding Nordic Bond. The plan allows for purchases of up to €5 million in nominal value, starting no earlier than 2 July and running through the end of the year, executed via Frankfurt and Tradegate by an independent financial institution. But crucially, the company retains the right to alter, suspend or cancel the program at any time. “The resolution creates a framework — not an execution,” the announcement effectively conceded. The market has so far yawned: the stock remains near its lows, having shed more than 61% over the past 30 days.

The most strategic item on the agenda is the planned acquisition of pharmaceutical wholesaler AEP, a deal that would add roughly €1.1 billion in annual revenues. The cartel office gave its blessing in the spring, but the financing structure is still unresolved. Management has set a firm deadline of the end of June — just days away — to close the transaction. Should it slip, the biggest transformative deal of the year for The Platform Group would be at serious risk. Shareholders will press for answers at the annual general meeting on 1 July in Düsseldorf, where capital measures including new authorised capital and convertible bonds are up for approval.

Against this grim backdrop, the operational figures continue to tell a different story. In the first quarter, net revenue surged to €243.1 million, adjusted EBITDA climbed to €21.8 million, and gross merchandise value (GMV) expanded from €356.3 million to €438.4 million. The customer base grew to 8.1 million, with partner numbers exceeding 17,000. The full-year outlook remains unchanged: GMV of €1.7 billion, net revenue of €1.0 billion, and adjusted EBITDA between €70 million and €80 million.

None of that is moving the needle. Whether the bond buyback turns into actual purchases from 2 July, how the AEP deal gets funded, and whether the legal clouds dissipate will determine if this disconnect between performance and price persists — or deepens.